Google快讯 - lung cancer

	lung cancer 实时更新 ⋅ 2025年1月1日
	新闻
	European Commission approves Janssen-Cilag International Rybrevant, Lazcluze combo ... Medical Dialogues Lung cancer is Europe's biggest cancer killer, with NSCLC accounting for 85 percent of all lung cancer cases. EGFR mutation-positive NSCLC refers ... 标记为不相关
	BMS's Opdivo gains FDA approval for faster subcutaneous cancer treatment - CHOSUNBIZ Chosunbiz - 조선일보 ... lung cancer, colorectal cancer, and gastric cancer. Global pharmaceutical companies are adopting formulation changes as a key strategy to defend ... 标记为不相关
查看更多结果 | 修改此快讯

您收到此电子邮件是因为您订阅了Google快讯。 退订 | 查看您所有的快讯

以RSS Feed的形式接收此快讯

发送反馈